858 results on '"Morrow, David A."'
Search Results
2. CD8 + T cell targeting of tumor antigens presented by HLA-E
3. Unveiling new horizons: revolutionary insights into acute myocarditis and optimal mechanical circulatory support timing
4. Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry
5. Moral bases of responses to climate change
6. Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry
7. Acute cardiac and intensive care chronicles: navigating the intersection of cardiovascular health, recreational drug use, and beyond!
8. Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure
9. Training Paradigms in Critical Care Cardiology
10. Pulmonary Artery Diastolic Pressure as a Surrogate for Pulmonary Capillary Wedge Pressure in Cardiogenic Shock
11. March 2024 issue of the European Heart Journal Acute Cardiovascular Care
12. Modes of Death in Patients with Cardiogenic Shock in the Cardiac Intensive Care Unit: A Report from the Critical Care Cardiology Trials Network
13. Acute cardiovascular and intensive care chronicles: ‘inception revealed—navigating the veno-arterial extracorporeal membrane oxygenation terrain and beyond’
14. Interhospital Variation in Admissions Managed With Critical Care Therapies or Invasive Hemodynamic Monitoring in Tertiary Cardiac Intensive Care Units: An Analysis From the Critical Care Cardiology Trials Network Registry
15. As we reflect on the year 2023…….
16. Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR‐TIMI 53, DECLARE‐TIMI 58 and CAMELLIA‐TIMI 61
17. Serial Assessment of Shock Severity in Cardiac Intensive Care Unit Patients
18. Editors' perspective
19. Cardiac arrest in the Extracorporeal Life Support (ECLS)-SHOCK trial in perspective
20. Abstract 18221: Interleukin-6 in Patients With HFrEF and the Effect of Dapagliflozin: Insights From DAPA-HF
21. Abstract 12495: Modes of In-Hospital Death in Patients With Cardiogenic Shock (CS): An Analysis From the Critical Care Cardiology Trials Network (CCCTN)
22. Abstract 16132: Cardiometabolic Risk Factors and Non-Culprit Plaque Characteristics in Patients With STEMI in REAL-TIMI 63B
23. Abstract 14745: Stem Cell Factor Associated With Critical Limb Ischemia in Patients With Peripheral Artery Disease
24. Abstract 13964: Dynamic Assessment of Shock Severity in Cardiac Intensive Care Unit Patients
25. A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH)
26. Complications in patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation therapy: distribution and relevance. Results from an international, multicentre cohort study.
27. Potential business model for a European vaccine R&D infrastructure and its estimated socio-economic impact
28. Resource use among patients with transcatheter cardiac valve procedures admitted to contemporary cardiac intensive care units: insights from CCCTN
29. Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)
30. Family Engagement in the Adult Cardiac Intensive Care Unit: A Survey of Family Engagement Practices in the Cardiac Critical Care Trials Network
31. In-perspective: ARAMIS: Double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis
32. Prognostic significance of haemodynamic parameters in patients with cardiogenic shock
33. Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events
34. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 inhibition in Patients with Type 2 Diabetes
35. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 inhibition in Patients with Type 2 Diabetes
36. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes
37. Pulmonary Artery Catheter Use and Mortality in the Cardiac Intensive Care Unit
38. Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial
39. A mission-driven research program on solar geoengineering could promote justice and legitimacy
40. Geoengineering
41. Toward ethical norms and institutions for climate engineering research
42. Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure
43. Single-cell transcriptomics reveal a hyperacute cytokine and immune checkpoint axis after cardiac arrest in patients with poor neurological outcome
44. Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes Mellitus
45. Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers
46. High-sensitivity cardiac troponin in stable atherosclerotic vascular disease
47. Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
48. Advances in the Management of Cardiogenic Shock
49. Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure
50. Correction: Hypergolic Continuous Detonation with Space-Storable Propellants and Additively-Manufactured Injector Design
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.